Edition:
United States

Ems Chemie Holding AG (EMSN.S)

EMSN.S on Swiss Exchange

663.50CHF
15 Dec 2017
Change (% chg)

CHF2.00 (+0.30%)
Prev Close
CHF661.50
Open
CHF662.50
Day's High
CHF667.00
Day's Low
CHF661.00
Volume
42,201
Avg. Vol
21,095
52-wk High
CHF712.50
52-wk Low
CHF501.00

Chart for

About

EMS-CHEMIE HOLDING AG is a Switzerland-based holding company and producer and supplier of polymers and chemicals. The Company operates in two business segments: High Performance Polymers and Specialty Chemicals. The High Performance Polymers business segment comprises EMS-GRIVORY, a manufacturer of high-performance polyamides... (more)

Overall

Beta: 1.06
Market Cap(Mil.): CHF15,518.62
Shares Outstanding(Mil.): 23.39
Dividend: 13.00
Yield (%): 2.56

Financials

  Industry Sector
P/E (TTM): -- 26.06 16.04
EPS (TTM): -- -- --
ROI: -- 16.98 34.69
ROE: -- 21.96 15.46

Brazil's EMS SA offers 16 mln euros for Serbia's Galenika

BELGRADE, Oct 26 An affiliate of Brazilian pharmaceuticals company EMS SA has offered 16 million euros ($18.8 million) for a 93.7 percent stake in Serbian drugmaker Galenika, the Balkan country's economy ministry said on Thursday.

Oct 26 2017

BRIEF-Ems Chemie Holding 9mth net sales up at CHF 1,598 mln

* IN THE FIRST 9 MONTHS OF 2017, NET SALES ROSE BY 6.7% COMPARED TO PREVIOUS YEAR TO REACH CHF 1,598 MLN

Oct 06 2017

Swiss Amicus and Brazil's EMS bid for Serbian drugmaker Galenika

BELGRADE Swiss-based drugs company Amicus SRB and Brazilian pharma group EMS SA have both made binding bids for a 93 percent stake in Serbian drugmaker Galenika, Serbia's Economy Ministry said.

Oct 04 2017

UPDATE 1-Swiss Amicus and Brazil's EMS bid for Serbian drugmaker Galenika

BELGRADE, Oct 4 Swiss-based drugs company Amicus SRB and Brazilian pharma group EMS SA have both made binding bids for a 93 percent stake in Serbian drugmaker Galenika, Serbia's Economy Ministry said.

Oct 04 2017

Swiss Amicus and Brazil's EMS bid for Serbian drugmaker Galenika

BELGRADE, Oct 4 Swiss-based drugs company Amicus SRB and Brazilian pharma group EMS SA have both made binding bids for a 93 percent stake in Serbian drugmaker Galenika, Serbia's Economy Ministry said.

Oct 04 2017

BRIEF-Ems Chemie Holding H1 net profit up at CHF 229 mln

* NET PROFIT FOR THE FIRST HALF OF 2017 WAS CHF 229 MILLION (215) WHICH IS 6.5% ABOVE THE PREVIOUS YEAR

Aug 28 2017

BRIEF-Ems Chemie H1 EBIT up at CHF 280 mln

* H1 CONSOLIDATED NET SALES IN SWISS FRANCS REACHED CHF 1,067 MILLION (1,002) WHICH REPRESENTS A GROWTH OF 6.5% COMPARED TO PREVIOUS YEAR

Jul 14 2017

Earnings vs. Estimates